Clinical Trials for Solid Tumors
TRIDENT-1
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1). View Details.
- Research
- Clinical Trials at UCBC
- Biliary Tract Cancer
- Bladder Cancer
- Brain & Spinal Cord Tumors
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Cancer
- Gastric Tumors
- Head & Neck Cancer
- Leukemia
- Kidney Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Multiple Myeloma
- Neuroendocrine Tumors
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Sarcoma Tumors
- Solid Tumors
- Uterine Cancer
